NetworkNewsBreaks

WednesdayMar 20, 2024 12:32 pm

NetworkNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Board Approves 1-for-10 Reverse Stock Split

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines for unmet medical needs, has announced a 1-for-10 reverse split of the company’s Class A common stock. The move was approved by the company’s board of directors during a special stockholder meeting. According to the announcement, the reverse split will become effective at 11:59 p.m. ET on March 26, 2024. Following that, the company’s Class A common stock will begin trading on the NASDAQ Capital Market on a split-adjusted basis. “The reverse split is intended to increase the per share trading price of the company’s common stock to enable the…

Continue Reading

WednesdayMar 20, 2024 12:23 pm

NetworkNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Developing Innovative Technologies to Address Critical Healthcare Challenges

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, recently expanded its therapeutic candidates, introducing ImmunePrep(TM) to improve the delivery of immunotherapeutic antibodies to treat cancer. “The company is also developing ChemoPrep(TM) and ChemoPure(TM) to optimize chemotherapy delivery and reduce treatment toxicity. The company further disclosed that clinical site locations for first-in-human studies for Sigyn Therapy(TM) have been identified. Sigyn Therapy(TM) is a novel blood purification technology to treat pathogen-associated conditions that are beyond the reach of drugs,” a recent article reads. “Sigyn Therapeutics is developing innovative medical technologies to address critical healthcare challenges. The company’s technologies show promise in…

Continue Reading

TuesdayMar 19, 2024 3:19 pm

NetworkNewsBreaks – SOBR Safe Inc.’s (NASDAQ: SOBR) Alcohol Detection Technology Poised to Improve Workplace Safety and Behavioral Outcomes

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”) has developed a patent-pending alcohol detection device to detect alcohol in humans with just a single touch of the finger. “SOBRsafe’s alcohol detection technology can improve workplace safety and provide advanced screening and monitoring solutions for the behavioral health industry… SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol through the user’s skin. No breath, blood or urine samples are required – making it a hygienic alternative to traditional breathalyzers,” a recent article reads. “SOBRsafe’s technology is integrated within the company’s robust and scalable platform, producing statistical and measurable user and business…

Continue Reading

TuesdayMar 19, 2024 2:45 pm

NetworkNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Expanding Operations Within Agricultural Sectors

SenesTech (NASDAQ: SNES), a rodent pest control enterprise, has begun to establish a global reach for its innovative Birth Control for Rats(TM) products. “The company is expanding its operations within agricultural sectors where rodent predation may otherwise have costly effects on food markets. On Jan. 29, SenesTech announced the signing of a distribution agreement with Poppe Enterprises LLC for the grain management market. Poppe Enterprises will be a stocking distributor for SenesTech’s Evolve(TM) soft bait in the outlets it serves in Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa, and Colorado, according to the announcement… SenesTech’s Evolve(TM) soft bait delivers…

Continue Reading

TuesdayMar 19, 2024 1:58 pm

NetworkNewsBreaks — C3is Inc. (NASDAQ: CISS) Releases Pricing on Estimated $6M Underwritten Public Offering

C3is (NASDAQ: CISS), a ship-owning company providing dry-bulk and crude oil tanker seaborne transportation services, announced pricing of its firm commitment underwritten public offering. The offering is estimated at $6 million before standard deductions and expenses. According to the announcement, the offering is comprised of  120,000,000 common units or prefunded units, each consisting of one share of common stock, one-half of a Class C-1 warrant to purchase one common share and one Class C-2 warrant to purchase one common share. The common units will be priced at $0.05, and the purchase price of each prefunded unit is $0.04. The company…

Continue Reading

TuesdayMar 19, 2024 1:54 pm

NetworkNewsBreaks – Graphjet Technology (NASDAQ: GTI) Commences Trading on the Nasdaq

Graphjet (NASDAQ: GTI), a leading developer of patented technologies to produce graphite and graphene directly from agricultural waste, and Energem Corp. (NASDAQ: ENCP, ENCPW) recently closed their previously announced business combination. The transaction, which was approved by Energem stockholders on Feb. 28, 2024, creates the only pure-play publicly traded direct biomass-to-graphite company, establishing Graphjet as the leading source of graphite and graphene for the U.S. market. On March 15, 2024, Graphjet’s ordinary shares began trading on the Nasdaq under the ticker symbol GTI. “We are thrilled to list Graphjet on the Nasdaq, particularly at this crucial moment of critical material…

Continue Reading

TuesdayMar 19, 2024 1:47 pm

NetworkNewsBreaks – Essential Portfolio Picks Showcased in Best Stocks Article

Best Stocks recently published an article titled “Essential Picks: 3 Stocks You Can’t Afford to Ignore.” The piece, written by Roberto Liccardo, discusses a profound transformation of the stock market landscape, where traditional performance metrics are overshadowed by the influence of artificial intelligence (“AI”). “The success stories of companies like Nvidia (NASDAQ: NVDA), Microsoft (NASDAQ: MSFT), Meta (NASDAQ: META), and AMD (NASDAQ: AMD) underscore AI’s pivotal role in driving stock prices to unprecedented heights. Conversely, companies that neglect to prioritize AI, such as Apple (NASDAQ: AAPL) in its recent pivot towards AI initiatives, risk falling behind in the ever-evolving market…

Continue Reading

TuesdayMar 19, 2024 12:38 pm

NetworkNewsBreaks – HealthLynked Corp. (HLYK) Welcomes Seasoned Tech, Product-Development Veteran as New CTO

HealthLynked (OTCQB: HLYK), a leader in healthcare technology innovation, announced that Chris Hall will the company’s new chief technology officer (CTO). Hall has gained invaluable expertise in technology and product development throughout his career; specifically, he has been involved in the launch of more than 100 products, has been responsible for more than a dozen patents and has managed global diverse teams. He comes to HealthLynked from Battelle, where he served as a senior product portfolio manager, and from HF Scientific, where he served as manager of new product development. Prior to that, he spent almost 20 years with Siemens…

Continue Reading

TuesdayMar 19, 2024 12:30 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The company today announced its entry into definitive agreements for the sale and issuance of 1,542,112 shares of its common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to 1,542,112 shares of common stock at a combined offering price of $4.215 per share of common stock (or per prefunded warrant in lieu thereof) and accompanying warrant, in a registered direct offering priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $4.09 per…

Continue Reading

TuesdayMar 19, 2024 12:09 pm

NetworkNewsBreaks – Clene Inc.’s (NASDAQ: CLNN) Work in Nanotechnology Highlighted in ‘First in Human’ Podcast

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, was featured in a recent episode of First in Human, a biotech-focused podcast featuring interviews with industry leaders and investors to learn about their journeys to in-human clinical trials. Hosted by Vial EVP Rich McCormick, the podcast is available for on-demand listening on First in Human by Vial. Rob Etherington, president, director and CEO of Clene joined the program to highlight information about the company’s work in the field of nanotechnology. “For decades…the idea of a therapeutic elemental metal having some medicinal efficacy has been well understood. We at Clene had the…

Continue Reading